Described herein are neuroactive steroids of the Formula (I): [Formula (I) should be inserted here] or a pharmaceutically acceptable salt thereof； wherein ------, A, R1, R2, and R3 are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use, e.g., for treating a subject suffering from a disease or disorder described herein.
